Bothersome menopausal symptoms amongst postmenopausal Iranian women

References

• Schoenaker DAJM, Jackson CA, Rowlands JV, et al. Socioeconomic position, lifestyle factors and age at natural menopause: a systematic review and meta-analyses of studies across six continents. Int J Epidemiol 2014;43:1542–62
   PubMed Web of Science ®Google Scholar
• World Health Organisation. 2018. Available from: http://www.who.int/countries/irn/en/
   Google Scholar
• Masoumi M, Azizi M, Atarod Z, et al. A systematic review of prevalence of vasomotor and sexual symptoms among Iranian middle-aged females. Iran Red Crescent Med J 2017;19:e43952
   Web of Science ®Google Scholar
• Gartoulla P, Worsley R, Bell RJ, et al. Moderate to severe vasomotor and sexual symptoms remain problematic for women aged 60 to 65 years. Menopause 2015;22:694–701
   PubMed Web of Science ®Google Scholar
• Freeman EW, Sammel MD, Sanders RJ. Risk of long-term hot flashes after natural menopause: evidence from the Penn Ovarian Aging Study cohort. Menopause 2014;21:924–32
   PubMed Web of Science ®Google Scholar
• Worsley R, Bell RJ, Gartoulla P, et al. Moderate–severe vasomotor symptoms are associated with moderate–severe depressive symptoms. J Women's Health 2017;26:712–18
   PubMed Web of Science ®Google Scholar
• The Presidency of Islamic Republic of Iran. Plan and Budget Organisation. Iran: Statistical Center of Iran; 2018. Available from: https://www.amar.org.ir/english/Population-and-Housing-Censuses
   Google Scholar
• Delavar MA, Hajiahmadi M. Age at menopause and measuring symptoms at midlife in a community in Babol, Iran. Menopause 2011;18:1213–18
   PubMed Web of Science ®Google Scholar
• Abedzadeh-Kalahroudi M, Taebi M, Sadat Z, et al. Prevalence and severity of menopausal symptoms and related factors among women 40-60 years in Kashan, Iran. Nurs Midwifery Stud 2012;1:88–93
   Google Scholar
• Ghassemzadeh H, Mojtabai R, Karamghadiri N, et al. Psychometric properties of a Persian-language version of the beck depression inventory–Second edition: BDI-II-Persian. Depress Anxiety 2005;21:185–92
   PubMed Web of Science ®Google Scholar
• Beck AT, Steer RA, Brown GK, Manual for the beck depression inventory-II. San Antonio, TX, USA: The Psychological Corporation, Harcourt, Brace and Co.; 1996
   Google Scholar
• Bell RJ, Lijovic M, Fradkin P, et al. A pragmatic approach to the classification of menopausal status for community-based research. Menopause 2008;15:978–83
   PubMed Web of Science ®Google Scholar
• Islam RM, Bell RJ, Billah B, et al. Prevalence and severity of vasomotor symptoms and joint pain in women at midlife in Bangladesh: a population-based survey. Menopause 2016;23:731–9
   PubMed Web of Science ®Google Scholar
• Thurston RC, Bromberger JT, Joffe H, et al. Beyond frequency: who is most bothered by vasomotor symptoms? Menopause 2008;15:841–7
   PubMed Web of Science ®Google Scholar
• Crawford SL. The roles of biologic and nonbiologic factors in cultural differences in vasomotor symptoms measured by surveys. Menopause 2007;14:725–33
   PubMed Web of Science ®Google Scholar
• Green R, Polotsky AJ, Wildman RP, et al. Menopausal symptoms within a Hispanic cohort: SWAN, the Study of Women’s Health Across the Nation. Climacteric 2010;13:376–84
   PubMed Web of Science ®Google Scholar
• Gold EB, Colvin A, Avis N, et al. Longitudinal analysis of the association between vasomotor symptoms and race/ethnicity across the menopausal transition: Study of Women’s Health Across the Nation. Am J Public Health 2006;96:1226–35
   PubMed Web of Science ®Google Scholar
• Gold EB, Block G, Crawford S, et al. Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the Study of Women’s Health Across the Nation. Am J Epidemiol 2004;159:1189–99
   PubMed Web of Science ®Google Scholar
• Haines CJ, Chung TKH, Leung DHY. A prospective study of the frequency of acute menopausal symptoms in Hong Kong Chinese women. Maturitas 1994;18:175–81
   PubMed Web of Science ®Google Scholar
• Simpkins JW, Brown K, Bae S, et al. Role of ethnicity in the expression of features of hot flashes. Maturitas 2009;63:341–6
   PubMed Web of Science ®Google Scholar
• Crandall CJ, Manson JE, Hohensee C, et al. Association of genetic variation in the tachykinin receptor 3 locus with hot flashes and night sweats in the Women's Health Initiative Study. Menopause 2017;24:252–61
   PubMed Web of Science ®Google Scholar
• Blumel JE, Chedraui P, Baron G, et al. A large multinational study of vasomotor symptom prevalence, duration, and impact on quality of life in middle-aged women. Menopause 2011;18:778–85
   PubMed Web of Science ®Google Scholar
• Avis NE, Crawford SL, Greendale G, et al. Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Intern Med 2015;175:531–9
   PubMed Web of Science ®Google Scholar
• Rashidy-Pour A, Malek M, Eskandarian R, et al. Obesity in the Iranian population. Obes Rev 2009;10:2–6
   PubMed Web of Science ®Google Scholar
• Kelishadi R, Alikhani S, Delavari A, et al. Obesity and associated lifestyle behaviours in Iran: findings from the first national non-communicable disease risk factor surveillance survey. Public Health Nutr 2008;11:246–51
   PubMed Web of Science ®Google Scholar
• Herber-Gast GC, Mishra GD, van der Schouw YT, et al. Risk factors for night sweats and hot flushes in midlife: results from a prospective cohort study. Menopause 2013;20:953–9
   PubMed Web of Science ®Google Scholar
• Gold EB, Sternfeld B, Kelsey JL, et al. Relation of demographic and lifestyle factors to symptoms in a multi-racial/ethnic population of women 40-55 years of age. Am J Epidemiol 2000;152:463–73
   PubMed Web of Science ®Google Scholar
• Fallahzadeh H, Hossienzadeh M, Yazdani F, et al. Knowledge of reproductive physiology and hormone therapy in 40-60 year old women: a population-based study in Yazd, Iran. Iran J Reprod Med 2012;10:383–90
   PubMedGoogle Scholar
• Rossouw J, Anderson G, Prentice R, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321–33
   PubMed Web of Science ®Google Scholar
• Haghighi L, Zadmohammadi M. Hormone replacement therapy in menopausal women refered to Iran University clinics during 2000-2001. Razi J Med Sci 2003;10:25–9
   Google Scholar
• Worsley R, Bell RJ, Gartoulla P, et al. Low use of effective and safe therapies for moderate to severe menopausal symptoms: a cross-sectional community study of Australian women. Menopause 2016;23:11–17
   PubMed Web of Science ®Google Scholar
• Jewett PI, Gangnon RE, Trentham-Dietz A, et al. Trends of postmenopausal estrogen plus progestin prevalence in the United States between 1970 and 2010. Obstet Gynecol 2014;124:727–33
   PubMed Web of Science ®Google Scholar
• Blümel JE, Chedraui P, Barón G, et al. A multicentric study regarding the use of hormone therapy during female mid-age (REDLINC VI). Climacteric 2014;17:433–41
   PubMed Web of Science ®Google Scholar